Out-of-pocket drug spending hit $98B in 2024: report
Why it matters: Lowering prescription drug costs remains a priority for both Democrats and Republicans.
The Biden administration led Congress in passing a landmark legislative package to negotiate select drug prices for seniors and redesign Medicare Part D. President Trump is continuing the focus, and recently signed an executive order aimed at further cutting drug prices.
What they found: Net spending on medicine rose 11.4% in 2024 to $487 billion. Prescription costs on average were flat compared with 2023, but there was greater use of medicines with significant clinical benefits, IQVIA said.
More than one-quarter of new prescriptions were not filled in 2024, mostly because they aren't covered by insurers.
Payer rejections may be driven by factors like prior authorization requirements or formulary decisions, but nearly half of those rejections are overcome either by the patient switching to a secondary insurer, paying cash, or adding a coupon, per IQVIA.
Looking ahead, total net spending on medications in the U.S. will exceed $600 billion by 2029, with obesity and oncology drugs driving growth, IQVIA estimates.
Zoom out: Prescription medicine use increased 1.7% last year, the report found.
The number of retail and long-term care prescriptions reached 7.1 billion, a nearly 1 billion increase since 2019. But growth in dispensed prescriptions in 2024 was slower than during the previous two years.
Stunning stats: Prescription opioid use fell to the lowest level since 1999, and overdose deaths decreased 29% in 2024.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
20 minutes ago
- Yahoo
Eli Lilly (LLY) Partners with Superluminal for AI Drug Discovery
Eli Lilly and Company (NYSE:LLY) is one of the 9 Best NYSE Stocks to Buy According to Hedge Funds. On August 14, Reuters reported that Eli Lilly and Company (NYSE:LLY) has entered into a deal worth $1.3 billion with Superluminal Medicines, a privately held company. The aim of this deal is to use AI to discover and develop small-molecule drugs for obesity and other cardiometabolic diseases. As per the report by Reuters, Eli Lilly and Company (NYSE:LLY) is already leading the obesity treatment market, which is expected to be worth $150 billion by the next decade. The company is looking to solidify its foothold in this area by developing next-generation drugs, making acquisitions, and entering into partnerships. The deal allows Eli Lilly and Company (NYSE:LLY) to have exclusive rights to develop and commercialize drug candidates discovered with the help of Superluminal's proprietary AI-driven platform targeting G-protein-coupled receptors (GPCR). These proteins can influence physiological processes including metabolism, cell growth, and immune responses. Eli Lilly and Company (NYSE:LLY) is an American multinational pharmaceutical company focused on discovering, developing, and delivering innovative medicines. While we acknowledge the potential of LLY as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 11 Best Revenue Growth Stocks to Buy Now and 14 Best Aggressive Growth Stocks to Buy According to Analysts. Disclosure: None. This article is originally published at Insider Monkey.
USA Today
an hour ago
- USA Today
Democrats try to force nuns to pay for abortions. Sounds authoritarian to me.
Blue states like California and Pennsylvania refuse to leave the Little Sisters of the Poor alone – and couldn't care less about their religious beliefs. The Little Sisters of the Poor are back in the news. In case you've forgotten who they are and why they matter, let's briefly review what they're all about. According to the group's website, the Little Sisters' mission is to ensure that "the elderly and dying are cared for with love and dignity until God calls them home.' The Little Sisters work in 31 countries and began work in America in 1868. Today, the nuns operate about 20 homes in the United States. It's a lovely mission and one that they should be allowed to do in peace, free from interference from the government. No such luck, however. Blue states like California and Pennsylvania refuse to leave the Little Sisters alone and couldn't care less about their religious beliefs. Since the Obama administration's Affordable Care Act birth control mandate that required employers to provide contraceptives and abortion-inducing drugs in their health insurance plans, the Little Sisters have been locked in a legal battle for the past 14 years. Despite clear wins for the nuns and religious liberty at the U.S. Supreme Court in 2016 and 2020, Democrats continue to persecute the Little Sisters. Will they ever stop? Will the Little Sisters have to make a third trip to the Supreme Court? That's 'absurd.' A federal district court in Philadelphia has revived the vindictive fight, siding with Pennsylvania and New Jersey against a 2017 Trump administration religious conscience rule, which offered the nuns and other religious groups protection from the mandate. Now, these states want the Little Sisters to offer contraception and abortion drugs or face millions of dollars in fines. 'The district court blessed an out-of-control effort by Pennsylvania and New Jersey to attack the Little Sisters and religious liberty,' Mark Rienzi, president of the Becket Fund for Religious Liberty and lead attorney for the Little Sisters, said in a statement. 'It is absurd to think the Little Sisters might need yet another trip to the Supreme Court to end what has now been more than a dozen years of litigation over the same issue.' The Little Sisters will appeal this decision, but it truly is ridiculous that they must waste time fighting the government in this way, when all they want to do is serve people in need. And lest you think it's odd to be talking about nuns and contraception, the Little Sisters employ lay people who work as nurses, cooks and serve other roles in the group's homes for the elderly. The nuns don't want to be complicit in providing services that directly violate their deep belief in the sanctity of life, which guides their work. They shouldn't have to. There are other ways the government could provide contraceptives to these employees without pushing the nuns to do it. Progressives claim Trump is an authoritarian. They should look at themselves. For all the times we've been scolded about how Trump and his supporters are fascists and Nazis, progressives ought to take a hard look at themselves first. Democrats have decided their views on culture are the only ones that should matter, religious liberty be damned. Look at how liberal governments have gone after Catholic adoption agencies, Christian bakers, website designers and farmers and tried to force them to betray their faith just to participate in the public square. These are often yearslong court battles, much like the Little Sisters have undertaken. Thankfully, we have a strong First Amendment that protects our speech and religious freedom. And the Supreme Court keeps ruling on the side of protecting these essential liberties, which are promised in our Constitution. Supreme Court Justice Clarence Thomas, in writing the majority for the 2020 case, observed that the Little Sisters 'have had to fight for the ability to continue in their noble work without violating their sincerely held religious beliefs.' Five years later, the fight continues. It's time for Democrats to leave these nuns alone. Ingrid Jacques is a columnist at USA TODAY. Contact her at ijacques@ or on X: @Ingrid_Jacques
UPI
3 hours ago
- UPI
AAP recommends children receive COVID-19 vaccine
The American Academy of Pediatrics is recommending children as young as six months receive the COVID-19 vaccine, despite the Trump administration stating it is not necessary for healthy children. File Photo by John Angelillo/UPI | License Photo Aug. 20 (UPI) -- The United States' leading pediatrics association is recommending that children as young as six months old be inoculated against COVID-19, going against the Trump administration, which stopped recommending healthy children receive the vaccine. The American Academy of Pediatrics made the recommendation Tuesday in the publication of its childhood and adolescent immunization schedule for this year. The report specifically recommends that children be inoculated against COVID-19 between the ages of six and 23 months, stating that those in this age range are at the highest risk of suffering the worst effects of the disease. "Children younger than 2 years old are especially vulnerable to severe COVID-19 and should be prioritized for vaccination unless they have a known allergy to the vaccine or its ingredients," the AAP said in a release accompanying the report. The AAP recommendation goes against that of Health and Human Services Secretary Robert F. Kennedy Jr., who in late May said the U.S. Centers for Disease Control and Prevention was no longer recommending that "healthy children" be immunized against COVID-19. Kennedy, a known vaccine skeptic, cited "a lack of any clinical data" to support booster COVID-19 shots for children. That move prompted AAP and other leading medical groups to sue Kennedy in July for making "unilateral, unscientific changes" to federal vaccine policy, calling it an "assault on science public health and evidence-based medicine." "This administration is an existential threat to vaccination in America, and those in charge are only just getting started," Richard Hughes IV, partner at Epstein Becker Green and lead counsel in the case, said in a statement. "If left unchecked, Secretary Kennedy will accomplish his goal of ridding the United States of vaccines, which would unleash a wave of preventable harm on our nation's children." Kennedy in June also fired all members of the CDC's Advisory Committee on Immunization Practices and replaced them with his own appointees, including three who have spoken out against the COVID-19 vaccine, two of whom have served as witnesses in lawsuits against vaccine makers and one who served on the board of the nation's oldest anti-vaccine group.
